Medigen Vaccine Biologics Corporation (6547.TWO)
Medigen Vaccine Biologics Corporation, a biotechnology drug company, engages in the research, development, and wholesale of vaccines and biopharmaceuticals, and medical devices in Taiwan.
45.80+0.00%Healthcare
StockGlow Score
Leaning Bullish
BearishBullish
1 year ago+6.1%
The outlook
Medigen Vaccine Biologics Corporation currently reads as leaning bullish based on mixed vs its moving averages, 44% of the way from its 52-week low to high, avg target +123% vs current price. This is a snapshot of current market data, not a forecast.
What’s behind the score
Price trendMixed vs its moving averages
52-week range44% of the way from its 52-week low to high
Price targetAvg target +123% vs current price
Market cap
$15.06B
52-wk high
61.20
52-wk low
33.50
50-day avg
46.47
200-day avg
42.54
Trailing P/E
—